Press release
August 3, 2026
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Zentalis Pharmaceuticals, Inc. (ZNTL)
We couldn't retrieve the full text for this release. Read it on the company's site.